香港股市 已收市
  • 恒指

    21,660.47
    -297.89 (-1.36%)
     
  • 國指

    7,387.02
    -118.77 (-1.58%)
     
  • 上證綜指

    3,263.41
    -22.26 (-0.68%)
     
  • 滬深300

    4,141.63
    -39.52 (-0.95%)
     
  • 美元

    7.8466
    +0.0032 (+0.04%)
     
  • 人民幣

    0.8627
    +0.0054 (+0.63%)
     
  • 道指

    33,926.01
    -127.93 (-0.38%)
     
  • 標普 500

    4,136.48
    -43.28 (-1.04%)
     
  • 納指

    12,006.96
    -193.86 (-1.59%)
     
  • 日圓

    0.0596
    -0.0012 (-1.91%)
     
  • 歐元

    8.4650
    -0.0884 (-1.03%)
     
  • 英鎊

    9.4570
    -0.1330 (-1.39%)
     
  • 紐約期油

    73.23
    -2.65 (-3.49%)
     
  • 金價

    1,865.90
    -50.40 (-2.63%)
     
  • Bitcoin

    23,184.30
    -259.23 (-1.11%)
     
  • CMC Crypto 200

    535.42
    -1.43 (-0.27%)
     

Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal

  • Ginkgo Bioworks Holdings Inc (NYSE: DNAagreed to acquire Zymergen Inc (NASDAQ: ZY) in an all-stock transaction.

  • Zymergen stockholders will receive 0.9179 shares of Ginkgo's Class A common stock for each Zymergen share. The deal values Zymergen at approximately $300 million and would provide Zymergen shareholders about 5.25% pro forma ownership of Ginkgo.

  • Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its foundry, including machine learning and data science tools for exploring genetic design space.

  • The agreement represents Ginkgo's largest acquisition to date and is expected to significantly enhance Ginkgo's platform by integrating robust automation and software capabilities.

  • Ginkgo customers will also benefit from expanding Ginkgo's library of biological assets ("Codebase") following the transaction.

  • The transaction is expected to be completed by the first quarter of 2023.

  • Price Action: DNA shares are down 4.62% at $2.79, and ZY stock is up 18.8% at $2.38 during the market session on the last check Monday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.